Cite
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
MLA
Rizzo, Alessio, et al. “Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.” International Journal of Molecular Sciences, vol. 24, no. 12, June 2023, p. 10136. EBSCOhost, https://doi.org/10.3390/ijms241210136.
APA
Rizzo, A., Racca, M., Garrou, F., Fenocchio, E., Pellegrino, L., Albano, D., Dondi, F., Bertagna, F., Annunziata, S., & Treglia, G. (2023). Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(12), 10136. https://doi.org/10.3390/ijms241210136
Chicago
Rizzo, Alessio, Manuela Racca, Federico Garrou, Elisabetta Fenocchio, Luca Pellegrino, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, and Giorgio Treglia. 2023. “Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.” International Journal of Molecular Sciences 24 (12): 10136. doi:10.3390/ijms241210136.